Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC-5214 as Add-On to Citalopram in MDD
NCT00692445Phase 2Completed
- Sponsor
- Targacept
- Start
- Jun 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of dexmecamylamine in major depressive disorder (MDD), sponsored by Targacept. Started Jun 2008; status: completed.
02
Drugs
dexmecamylamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00692445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00692445.